Implant-retained prosthetic rehabilitation of orbital defects.
OBJECTIVE
To evaluate the use of endosseous transcutaneous implants to retain removable facial prostheses for the rehabilitation of orbital defects.


METHODS
Tertiary referral center.


METHODS
Six patients with a history of facial defects secondary to orbital exenteration for cancer ablation.


METHODS
Clinically noted functional and cosmetic results, patient reports of satisfaction, and complications encountered.


RESULTS
Twenty-three of 25 implants were integrated (postoperative period, 13 to 65 months; mean, 44.2 months), representing an integration success rate of 92%. All patients were successfully wearing implant-retained prostheses after 48.3 months (post-prosthesis delivery period, 1 to 48.3 months; mean, 24.5 months). Overall patient satisfaction was very high.


CONCLUSIONS
Implant-retained prosthetics represent a safe and effective treatment option. It is anticipated that this treatment will become the standard of rehabilitative care for patients with orbital defects.
Moran
W J
WJ
Section of Otolaryngology, University of Chicago Medical Center, Ill., USA.
Toljanic
J A
JA
Panje
W R
WR
D000328:Adult; D000368:Aged; D005137:Eye, Artificial / Q000009:adverse effects / Q000523:psychology / Q000592:standards*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017233:Orbit Evisceration / Q000009:adverse effects / Q000534:rehabilitation*; D009918:Orbital Neoplasms / Q000601:surgery*; D016348:Osseointegration; D017060:Patient Satisfaction